[1] Bankar GR, Keoliya A. Robot-assisted surgery in gynecology. Cureus 2022. 10.7759/cureus.29190.
[2] Fu H, Zhang J, Zhao S, He N. Survival outcomes of robotic-assisted laparoscopy versus conventional laparoscopy and laparotomy for endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol 2023;174:55–67. 10.1016/j.ygyno.2023.04.026.
[3] Dowdy SC, Borah BJ, Bakkum-Gamez JN, Kumar S, Weaver AL, et al. Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstet Gynecol 2012;120(6):1419–27. 10.1097/AOG.0b013e3182737538.
[4] Chaouch MA, Leblanc-Even P, Loghmari A, Da Costa AC, Mazzotta A, et al. Robotic versus laparoscopic lateral lymph node dissection for advanced pelvic cancers: a systematic review and meta-analysis. J Gastrointest Canc 2025;56(1):151. 10.1007/s12029-025-01251-7.
[5] Nobbenhuis MAE, Gul N, Barton-Smith P, O'Sullivan O, Moss E, et al. Robotic surgery in gynaecology: Scientific Impact Paper No. 71 (July 2022). BJOG 2023;130(1). 10.1111/1471-0528.17242.
[6] Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med 2018;379(20):1895–904. 10.1056/NEJMoa1806395.
[7] Čelebić A, Jakimovska Stefanovska M, Miladinović M, Calleja-Agius J, Drusany Starič K. Evaluating the role of robotic surgery in gynecological cancer treatment. Eur J Surg Oncol 2025;51(4):109630. 10.1016/j.ejso.2025.109630.
[8] Concin N, Matias-Guiu X, Cibula D, Colombo N, Creutzberg CL, et al. ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025. Lancet Oncol 2025;26(8):e423–35. 10.1016/S1470-2045(25)00167-6.
[9] Lawrie TA, Liu H, Lu D, Dowswell T, Song H, et al. Robot-assisted surgery in gynaecology. Cochrane Database Syst Rev 2019;4(4):CD011422. 10.1002/14651858.CD011422.pub2.
[10] Narducci F, Bogart E, Hebert T, Gauthier T, Collinet P, et al. Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial. Gynecol Oncol 2020;158(2):382–9. 10.1016/j.ygyno.2020.05.010.
[11] Dinoi G, Tarantino V, Bizzarri N, Perrone E, Capasso I, et al. Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese). Int J Gynecol Cancer 2024;34(5):773–6. 10.1136/ijgc-2023-005197.
[12] Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The ROLARR Randomized Clinical Trial. JAMA 2017;318(16):1569–77. 10.1001/jama.2017.7219.
[13] Eoh KJ, Kim TJ, Park JY, Kim HS, Paek J, et al. Robot-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term comparison of outcomes. Front Oncol 2023;13:1219371. 10.3389/fonc.2023.1219371.
[14] Albright BB, Witte T, Tofte AN, Chou J, Black JD, et al. Robotic versus laparoscopic hysterectomy for benign disease: a systematic review and meta-analysis of randomized trials. J Minim Invasive Gynecol 2016;23(1):18–27. 10.1016/j.jmig.2015.08.003.
[15] Corrado G, Vizza E, Perrone AM, Mereu L, Cela V, et al. Comparison between laparoscopic and robotic surgery in elderly patients with endometrial cancer: a retrospective multicentric study. Front Oncol 2021;11:724886. 10.3389/fonc.2021.724886.
[16] Soto E, Luu TH, Liu X, Magrina JF, Wasson MN, et al. Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a multicenter, randomized, controlled trial. Fertil Steril 2017;107(4):996–1002.e3. 10.1016/j.fertnstert.2016.12.033.
[17] Lambaudie E, Bogart E, Le Deley MC, El Hajj H, Gauthier T, et al. The influence of surgical complexity and center experience on postoperative morbidity after minimally invasive surgery in gynecologic oncology: lessons learned from the ROBOGYN-1004 Trial. Ann Surg Oncol 2024;31(7):4566–75. 10.1245/s10434-024-15265-1.
[18] Jauffret C, Lambaudie E, Esterni B, Bannier M, Buttarelli M, et al. Learning curve of robot-assisted laparoscopy in gynecologic oncology surgery: team training and impact on morbidity. Clin Surg 2016;1:1112. 10.25107/2474-1647.1112.
[19] Jørgensen SL, Mogensen O, Wu CS, Korsholm M, Lund K, et al. Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study. Eur J Cancer 2019;109:1–11. 10.1016/j.ejca.2018.12.004.
[20] Concin N, Planchamp F, Abu-Rustum NR, Ataseven B, Cibula D, et al. European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. Int J Gynecol Cancer 2021;31(12) 10.1136/ijgc-2021-003178.
[21] Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023. Int J Gynecol Cancer 2023;33(5):649–66. 10.1136/ijgc-2023-004429.
[22] Arbyn M, Weiderpass E, Bruni L, De Sanjosé S, Saraiya M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8(2):e191–203. 10.1016/S2214-109X(19)30482-6.
[23] Zhou J, Xiong BH, Ma L, Cheng Y, Huang W, et al. Robotic vs laparoscopic radical hysterectomy for cervical cancer: a meta-analysis. Int J Med Robot 2016;12(1):145–54. 10.1002/rcs.1652.
[24] Dai Z, Qin F, Yang Y, Liang W, Wang X. Efficacy and safety of robotic radical hysterectomy in cervical cancer compared with laparoscopic radical hysterectomy: a meta-analysis. Front Oncol 2024;14:1303165. 10.3389/fonc.2024.1303165.
[25] Hwang JH, Kim B. Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis. J Gynecol Oncol 2024;35(1):e9. 10.3802/jgo.2024.35.e9.
[26] Bae JH, Song J, Yoo RN, Kim JH, Kye BH, et al. Robotic lateral pelvic lymph node dissection could harvest more lateral pelvic lymph nodes over laparoscopic approach for mid-to-low rectal cancer: a multi-institutional retrospective cohort study. Biomedicines 2023;11(6):1556. 10.3390/biomedicines11061556.
[27] Feng Q, Yuan W, Li T, Tang B, Jia B, et al. Robotic vs Laparoscopic Surgery for Middle and Low Rectal Cancer: The REAL Randomized Clinical Trial. JAMA 2025;334(2):136. 10.1001/jama.2025.8123.
[28] Ramirez PT, Robledo KP, Frumovitz M, Pareja R, Ribeiro R, et al. LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer. J Clin Oncol 2024;42(23):2741–6. 10.1200/JCO.23.02335.
[29] Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med 2018;379(20):1905–14. 10.1056/NEJMoa1804923.
[30] Falconer H, Palsdottir K, Stalberg K, Dahm-Kähler P, Ottander U, et al. Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial. Int J Gynecol Cancer 2019;29(6):1072–6. 10.1136/ijgc-2019-000558.
[31] Leitao MM, Bixel KL, Chase DM, Quick A, McCormick C, et al. ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer. Int J Gynecol Cancer 2025;35(7):101760. 10.1016/j.ijgc.2025.101760.
[32] Cibula D, Planchamp F, Fischerova D, Fotopoulou C, Kohler C, et al. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer. Int J Gynecol Cancer 2020;30(1):3–14. 10.1136/ijgc-2019-000878.
[33] Espías-Alonso M, Gorostidi M, Zapardiel I, Gracia M. Assessment of ESGO quality indicators and factors associated with recurrence following surgery for early-stage cervical cancer: a retrospective cohort study. J Clin Med 2025;14(19):7041. 10.3390/jcm14197041.
[34] Pervan M, Ramirez PT. Single-port robotic surgery: innovation, evolution, or illusion? Int J Gynecol Cancer 2026;36(5):104688. 10.1016/j.ijgc.2026.104688.
[35] Ribero L, Schivardi G, Achilarre MT, Aloisi A, Betella I, et al. Single-port robotic surgery in gynecologic oncology: feasibility and safety after 1 year of implementation. Int J Gynecol Cancer 2026;36(5):104481. 10.1016/j.ijgc.2026.104481.
